HI
SQZ

Harbour Investments’s SQZ Biotechnologies Company SQZ Stock Holding History

Harbour Investments’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13
Closed – – 3901
2021
Q3 		$0 Sell
13
-6
-32% -$81 ﹤0.01% 4088
2021
Q2 		$0 Sell
19
-1
-5% -$13 ﹤0.01% 4045
2021
Q1 		$0 Buy
+20
New +$406 ﹤0.01% 3775

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbour Investments's SQZ Position: Q4 2021 in Review

Harbour Investments sold out of SQZ Biotechnologies Company (SQZ) in Q4 2021, closing a stake of 13 shares.

Harbour Investments first reported a position in SQZ in Q1 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 50 funds tracked by Wall St. Rank hold SQZ as of Q4 2021.

  • Harbour Investments reported no remaining SQZ Biotechnologies Company position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 13 SQZ Biotechnologies Company shares in Q4 2021.
  • Harbour Investments first reported a position in SQZ Biotechnologies Company in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's SQZ Biotechnologies Company position peaked at $0 in Q3 2021.
  • 50 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.